Abstract
INTRODUCTION
Neiguan (PC 6) , an acupoint of the pericardial meridian, has been widely used for treating cardiovascular disease. [1] [2] [3] [4] Previous studies have found that electroacupuncture (EA) at Neiguan (PC 6) protects myocardial cells against ischemia by reducing heart rate, blood pressure, and O2 demand, and in particular the last effect may regulate supply-demand imbalance and thereby lessen the extent of ischemia. [5] [6] [7] [8] These beneficial effects of EA at Neiguan are caused by inhibition of the cardiac sympathetic system. 9, 10 Generally, cardiac sympathetic nerve excitation causes norepinephrine (NE) release, which in turn binds to β1 receptors, triggering sodium (Na + ) influx via voltage-gated Na + channels (Nav) and promoting myocardial cell contraction. Thus, Na + influx is necessary for myocardial contraction. There are various Na + influx paths including Nav, Na and other co-transporters, although Nav are the most important. 11, 12 By contrast, the Na overload and mitochondrial damage, causing rapid and obvious contractile dysfunction. Attenuation of Na + overload via inhibition of Na + influx can preserve mitochondrial energy production in ischemic myocardium and enhance post-ischemic contractile recovery. In ischemia, cardioprotection mediated by EA at Neiguan (PC 6) has been confirmed; however, the effect on voltage-gated Na + currents (INa) and Nav kinetics is still not clear. Accordingly, in the present study we examined the electrophysiological mechanism of EA-mediated cardioprotection using the whole-cell patch-clamp technique to investigate the effect of EA at Neiguan (PC 6) on INa and Nav following rat ventricular myocyte mimicked ischemia.
MATERIALS AND METHODS

EA serum preparation
Twelve male adult Sprague-Dawley (SD) rats of specific pathogen-free (SPF) grade, [3 months old, weighing (240 ± 10) g] were purchased from Liaoning Changsheng Biotechnology Company Limited, Benxi, China [SCXK (Liao) 2010-0001]. Animal care procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Every effort was made to minimize suffering. The animal use protocol was reviewed and approved by the Experimental Animal Ethics Committee of Liaoning University of Traditional Chinese Medicine. The EA method at bilateral Neiguan (PC 6) has been described previously.
14 After 7 days of acupuncture treatment, six rats were anaesthetized with 10% chloral hydrate (10 mg/kg). Rat blood samples were collected using the abdominal aortic blood collection method, and centrifuged at 3000 rpm for 10 min. Supernatants were extracted and cryopreserved.
Solutions and reagents
Collagenase II and tetrodotoxin (TTX) were purchased from Sigma (St. Louis, MO, USA). All other reagents were from Sinopharm Chemical Reagent Shenyang Co., Ltd., (Shenyang, China). Tyrode solution consisted of (in mmol/L): NaCl 137.0, CaCl2 1. 
Electrophysiological recordings
Eighteen ventricular cells were isolated from six rat hearts using a collagenase Ⅱ method. 15 Briefly, rats were anaesthetized with 10% choral hydrate (10 mg/ kg); hearts were then dissected and mounted on a Langerdorff apparatus (Chengdu, Sichuan, China). Coronary arteries were retrograde-perfused with Ca 2+ -free Tyode solution for 5 min, and then collagenase Ⅱ solution (0.4 mg/mL) for 30 min. Next, hearts were dissected, cut into pieces, and transferred into Tyrode solution. The suspension was filtered (using a 200 μM × 200 μM mesh) and stored at room temperature in KB solution. Rod-shaped cardiomyocytes were used to form giga-seals with patch pipettes. Whole-cell patch-clamp recordings were performed at room temperature (22℃-24℃ ) using an EPC10 patch-clamp amplifier (HEKA, Lambrecht, Germany), as described previously. 16 Briefly, signals were filtered at 5 kHz and digitized at a 2-kHz sampling rate. Series resistance was compensated by at least 60% . Leakage and capacitive currents were subtracted on-line using a P/4 subtraction procedure. After giga-seal formation and membrane rupture, cells were stabilized for 3-5 min before starting protocols. Three currents were induced from one single cell sequentially. The first current was the control and recorded in the absence of ischemic solution, the second was recorded after perfusion of ischemic solution for 5 min, and the last after perfusion of EA serum for 5 min.
Data analysis
All data were analyzed and fitted using Clampfit 9.0 (vers 9.2.0.09 Axon Instruments, Inc., Sunnyvale, CA, USA) and Origin 8.0 (vers 8.0724, OriginLab Corporation, Northampton, MA, USA). Values were represented as mean ± standard deviation (SD). Statistical comparisons were performed using Student's t-test. Values of P<0.05 were considered significant.
RESULTS
Effect of EA serum on current-voltage (I-V) curves of INa
INa was obtained by 20-ms depolarizing pulses from the holding potential of -70 mV to + 70 mV at 10-mV steps. Activated inward currents were completely and reversibly blocked by bath application of 0.5 μM TTX (data not shown), indicating that expressed Nav were TTX-sensitive. In the presence of ischemic solution, peak INa amplitudes increased significantly from -40 mV to +30 mV (n=6; P<0.05, P<0.01 vs control currents), and in the presence of EA serum, peak INa amplitudes decreased significantly from -40 mV to +40 mV (n=6; P<0.05 vs ischemic currents) ( Figure 1 ).
Effect of EA serum on steady-state activation curves of Nav According to I-V curves of INa, currents from -70 mV to +30 mV are converted to conductance (G) using the following formula: G=I/(Vm-Vr), with Vr the reversal potential. Peak conductance values for each test potential were normalized to Gmax and plotted against the test potential to produce voltage-conductance relationship curves that fitted well using the Boltzmann function: G/Gmax=1/{1+exp[−(V−Vh)/k]}, with Vh the voltage at which conductance is half-maximal, and k the slope factor. Our results found that both Vh and k were unaltered by ischemic solution and EA serum (n=6, P> 0.05) (Figure 2 , Table 1 ), suggesting that neither of them altered the steady-state activation kinetics of Nav.
Effect of EA serum on steady-state inactivation curves of Nav Steady-state INa inactivation was elicited by a 100-ms conditioning prepulse to potentials between -80 mV and +20 mV in 10-mV increments, followed by a 20-ms pulse of -30 mV and holding potential at -70 mV. Peak INa amplitudes were normalized and plotted against command potentials, with the resulting data well fitted using the Boltzmann function: I/Imax=1/{1+ exp[(V−Vh)/k]}, with I/Imax being the normalized current, Vh the potential for half-maximal inactivation, and k the slope factor. Our results found that in the presence of ischemic solution, Nav steady-state inactivation curves shifted significantly in a positive direction, and were restored by EA serum ( Figure 3 , Table 2 ).
Effect of EA on Nav recovery time course
Currents were obtained using the following protocol: holding potential at -80 mV followed by a 50-ms conditioning depolarizing pulse (-40 mV) to fully inactivate Nav, and then a 50-ms test pulse (-40 mV) after a series of -90-mV intervals varying from 2-36 ms (in 2-ms increments). Peak INa values evoked by the conditioning pulse were designated I1, while those evoked by the test pulse were designated I2. The I2 to I1 ratio represents INa recovery from inactivation. The plot of I2 to I1 vs duration of -80-mV intervals was fitted using a monoexponential function: I/Imax=A+Bexp(-t/τ), with τ being the time constant for recovery from inactivation. No significant differences were found (Figure 4 , Table 3 ).
DISCUSSION
Myocardial Na + concentration in ischemic heart increases in an ischemic duration-dependent manner. 17, 18 There are various Na + influx paths including Nav, Na leading to contractile failure. 21 Therefore, inhibition of Na + influx, especially Nav blockage, may be a promising approach to protect ischemic myocardiocytes. In the present study, we found that peak INa amplitudes significantly increased from -40 mV to + 30 mV in the presence of ischemic solution, suggesting that mimicking ischemia increased Na + influx. After perfusion of EA serum, incremental INa peak amplitudes markedly reduced from -40 mV to +40 mV, suggesting that EA at bilateral Neiguan (PC 6) may oppose INa enhancement caused by ischemia, and reduce Na + influx. INa provides the electrical energy for electrical impulse propagation between myocardiocytes and determines cardiac conduction speed, therefore INa inhibition can not only protect ischemic myocardiocytes but also restrict the ischemic area. Indeed, it has been reported that EA at Neiguan (PC 6) restricts the ischemic area and reduces infarct size, 10 and potentially the electrophysiological mechanism may be related to EA inhibition of INa. Generally, INa intensity is determined by Nav kinetics, hence we examined the effect of EA serum on Nav. We found Nav expressed on myocardiocytes were TTX-sensitive, and such channels can complete state transitions between resting, fast activated, and inactivated states in a few milliseconds or less. 22 Myocardiocyte depolarization to the threshold potential activates Nav and causes a very large but brief INa. We did not observe a significant shift in Nav steady-state activation curves in the presence of either ischemic solution or EA serum, suggesting that neither affected activation kinetics of Nav. With regards to Nav inactivation kinetics, we found that in the presence of ischemic solution, steady-state inactivation curves shifted significantly in a positive direction, indicating that ischemia delayed Nav inactivation. It is known that appropriate Nav inactivation is essential for effective action potential repolarization; 23 however, delayed inactivation can produce large inward Na + currents during the cardiac action potential plateau, causing repolarization failure, early post-depolarization, and life-threatening ventricular tachyarrhythmia. 24 Accordingly, restoration of abnormal Nav inactivation caused by ischemia is cardioprotective. We found that in the presence of EA serum, positively shifted steady-state NaV inactivation curves caused by ischemia had shifted in a negative direction, and there was no significant difference in Vh value compared with controls. This suggests that EA at Neiguan (PC 6) can restore abnormal Nav inactivation. To understand EA-mediated cardioprotection in ischemia, we calculated Nav activation intervals based on our Nav activation and inactivation results, as the interval between Nav activation and inactivation is closely related to INa intensity. 25 In the absence of ischemic solution, the Nav open interval was between -53.97 mV and -43.25 mV and approximately 10.72 mV in width. However, in the presence of ischemic solution, it was between -55.81 mV and -32.90 mV and approximately 22.91 mV in width. These results suggest that the Nav activation interval broadened during ischemia, and such a change may contribute to INa enhancement in mimicked ischemia. After perfusion of EA serum, the Nav activation interval was between -51.90 mV and -36.15 mV with a width of 15.75 mV, less compared with ischemia, suggesting that EA shortened the broadened activation interval caused by ischemic solution, resulting in decreased INa. After rapid activation and inactivation, the membrane potential is far removed from the Nav activation threshold, and Nav recovery from inactivation is needed. Our results show that the Nav recovery time from inactivation to activation is not affected by either ischemic solution or EA serum, suggesting that neither has a significant effect on Nav recovery from inactivation. In conclusion, ischemia increases INa by delaying Nav inactivation and broadening the Nav activation interval, which can be restored by EA at bilateral Neiguan (PC 6). Our study suggests that EA at bilateral Neiguan (PC 6) may attenuate Na + overload and promote functional recovery in ischemic ventricular myocytes.
